Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring

V. Sorbello, B. Pergolizzi, A. Sillo, S. Bozzaro, V. De Rose (Orbassano, Italy)

Source: Annual Congress 2006 - Molecular airway biology
Session: Molecular airway biology
Session type: Oral Presentation
Number: 954
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Sorbello, B. Pergolizzi, A. Sillo, S. Bozzaro, V. De Rose (Orbassano, Italy). Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring. Eur Respir J 2006; 28: Suppl. 50, 954

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009


Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis
Source: Eur Respir J 2016; 48: 1612-1621
Year: 2016



New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005

Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007



Application of omics technologies to the identification of biomarkers for COPD
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007



Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Comparison of EBC biomarkers in cystic fibrosis and bacterial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006

Biomarker discovery in chronic obstructive pulmonary disease (COPD) using epithelial lining fluid: A proteomic approach
Source: Annual Congress 2011 - Phenotyping airway diseases
Year: 2011



Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014

Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013



Proteomic derived biomarkers for COPD are present in induced sputum
Source: Eur Respir J 2005; 26: Suppl. 49, 439s
Year: 2005

Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012


Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes
Source: Eur Respir J, 55 (4) 2000105; 10.1183/13993003.00105-2020
Year: 2020



Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020


Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015


The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006